In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem,
In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem, Israel, has developed algorithms that detect and classify breast lesions. Siemens may leverage the technology, which is now undergoing clinical validation, across several applications and multiple modalities.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.